Host STING-dependent MDSC mobilization drives extrinsic radiation resistance

Hua Liang, Liufu Deng, Yuzhu Hou, Xiangjiao Meng, Xiaona Huang, Enyu Rao, Wenxin Zheng, Helena Mauceri, Matthias Mack, Meng Xu, Yang Xin Fu, Ralph R. Weichselbaum

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Radiotherapy induces and promotes innate and adaptive immunity in which host STING plays an important role. However, radioresistance in irradiated tumors can also develop, resulting in relapse. Here we report a mechanism by which extrinsic resistance develops after local ablative radiation that relies on the immunosuppressive action of STING. The STING/type I interferon pathway enhances suppressive inflammation in tumors by recruiting myeloid cells in part via the CCR2 pathway. Germ-line knockouts of CCR2 or treatment with an anti-CCR2 antibody results in blockade of radiation-induced MDSC infiltration. Treatment with anti-CCR2 antibody alleviates immunosuppression following activation of the STING pathway, enhancing the anti-tumor effects of STING agonists and radiotherapy. We propose that radiation-induced STING activation is immunosuppressive due to (monocytic) M-MDSC infiltration, which results in tumor radioresistance. Furthermore, the immunosuppressive effects of radiotherapy and STING agonists can be abrogated in humans by a translational strategy involving anti-CCR2 antibody treatment to improve radiotherapy.

Original languageEnglish (US)
Article number1736
JournalNature Communications
Volume8
Issue number1
DOIs
StatePublished - Dec 1 2017

Fingerprint

Radiotherapy
radiation tolerance
Tumors
radiation therapy
tumors
Immunosuppressive Agents
antibodies
Radiation
Anti-Idiotypic Antibodies
infiltration
Infiltration
Antibodies
Neoplasms
radiation
immunosuppression
Chemical activation
interferon
activation
Interferon Type I
immunity

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

Liang, H., Deng, L., Hou, Y., Meng, X., Huang, X., Rao, E., ... Weichselbaum, R. R. (2017). Host STING-dependent MDSC mobilization drives extrinsic radiation resistance. Nature Communications, 8(1), [1736]. https://doi.org/10.1038/s41467-017-01566-5

Host STING-dependent MDSC mobilization drives extrinsic radiation resistance. / Liang, Hua; Deng, Liufu; Hou, Yuzhu; Meng, Xiangjiao; Huang, Xiaona; Rao, Enyu; Zheng, Wenxin; Mauceri, Helena; Mack, Matthias; Xu, Meng; Fu, Yang Xin; Weichselbaum, Ralph R.

In: Nature Communications, Vol. 8, No. 1, 1736, 01.12.2017.

Research output: Contribution to journalArticle

Liang, H, Deng, L, Hou, Y, Meng, X, Huang, X, Rao, E, Zheng, W, Mauceri, H, Mack, M, Xu, M, Fu, YX & Weichselbaum, RR 2017, 'Host STING-dependent MDSC mobilization drives extrinsic radiation resistance', Nature Communications, vol. 8, no. 1, 1736. https://doi.org/10.1038/s41467-017-01566-5
Liang, Hua ; Deng, Liufu ; Hou, Yuzhu ; Meng, Xiangjiao ; Huang, Xiaona ; Rao, Enyu ; Zheng, Wenxin ; Mauceri, Helena ; Mack, Matthias ; Xu, Meng ; Fu, Yang Xin ; Weichselbaum, Ralph R. / Host STING-dependent MDSC mobilization drives extrinsic radiation resistance. In: Nature Communications. 2017 ; Vol. 8, No. 1.
@article{f5f4f111accf45369d5b213fe67f5393,
title = "Host STING-dependent MDSC mobilization drives extrinsic radiation resistance",
abstract = "Radiotherapy induces and promotes innate and adaptive immunity in which host STING plays an important role. However, radioresistance in irradiated tumors can also develop, resulting in relapse. Here we report a mechanism by which extrinsic resistance develops after local ablative radiation that relies on the immunosuppressive action of STING. The STING/type I interferon pathway enhances suppressive inflammation in tumors by recruiting myeloid cells in part via the CCR2 pathway. Germ-line knockouts of CCR2 or treatment with an anti-CCR2 antibody results in blockade of radiation-induced MDSC infiltration. Treatment with anti-CCR2 antibody alleviates immunosuppression following activation of the STING pathway, enhancing the anti-tumor effects of STING agonists and radiotherapy. We propose that radiation-induced STING activation is immunosuppressive due to (monocytic) M-MDSC infiltration, which results in tumor radioresistance. Furthermore, the immunosuppressive effects of radiotherapy and STING agonists can be abrogated in humans by a translational strategy involving anti-CCR2 antibody treatment to improve radiotherapy.",
author = "Hua Liang and Liufu Deng and Yuzhu Hou and Xiangjiao Meng and Xiaona Huang and Enyu Rao and Wenxin Zheng and Helena Mauceri and Matthias Mack and Meng Xu and Fu, {Yang Xin} and Weichselbaum, {Ralph R.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41467-017-01566-5",
language = "English (US)",
volume = "8",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Host STING-dependent MDSC mobilization drives extrinsic radiation resistance

AU - Liang, Hua

AU - Deng, Liufu

AU - Hou, Yuzhu

AU - Meng, Xiangjiao

AU - Huang, Xiaona

AU - Rao, Enyu

AU - Zheng, Wenxin

AU - Mauceri, Helena

AU - Mack, Matthias

AU - Xu, Meng

AU - Fu, Yang Xin

AU - Weichselbaum, Ralph R.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Radiotherapy induces and promotes innate and adaptive immunity in which host STING plays an important role. However, radioresistance in irradiated tumors can also develop, resulting in relapse. Here we report a mechanism by which extrinsic resistance develops after local ablative radiation that relies on the immunosuppressive action of STING. The STING/type I interferon pathway enhances suppressive inflammation in tumors by recruiting myeloid cells in part via the CCR2 pathway. Germ-line knockouts of CCR2 or treatment with an anti-CCR2 antibody results in blockade of radiation-induced MDSC infiltration. Treatment with anti-CCR2 antibody alleviates immunosuppression following activation of the STING pathway, enhancing the anti-tumor effects of STING agonists and radiotherapy. We propose that radiation-induced STING activation is immunosuppressive due to (monocytic) M-MDSC infiltration, which results in tumor radioresistance. Furthermore, the immunosuppressive effects of radiotherapy and STING agonists can be abrogated in humans by a translational strategy involving anti-CCR2 antibody treatment to improve radiotherapy.

AB - Radiotherapy induces and promotes innate and adaptive immunity in which host STING plays an important role. However, radioresistance in irradiated tumors can also develop, resulting in relapse. Here we report a mechanism by which extrinsic resistance develops after local ablative radiation that relies on the immunosuppressive action of STING. The STING/type I interferon pathway enhances suppressive inflammation in tumors by recruiting myeloid cells in part via the CCR2 pathway. Germ-line knockouts of CCR2 or treatment with an anti-CCR2 antibody results in blockade of radiation-induced MDSC infiltration. Treatment with anti-CCR2 antibody alleviates immunosuppression following activation of the STING pathway, enhancing the anti-tumor effects of STING agonists and radiotherapy. We propose that radiation-induced STING activation is immunosuppressive due to (monocytic) M-MDSC infiltration, which results in tumor radioresistance. Furthermore, the immunosuppressive effects of radiotherapy and STING agonists can be abrogated in humans by a translational strategy involving anti-CCR2 antibody treatment to improve radiotherapy.

UR - http://www.scopus.com/inward/record.url?scp=85034849536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034849536&partnerID=8YFLogxK

U2 - 10.1038/s41467-017-01566-5

DO - 10.1038/s41467-017-01566-5

M3 - Article

VL - 8

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

IS - 1

M1 - 1736

ER -